
Results
4
Big ticket companies showing a potential underpricing based on intrinsic value
4 companies
AstraZeneca
Market Cap: UK£178.4b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£115.00
7D
-11.1%
1Y
2.5%
GSK
Market Cap: UK£76.5b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.10
7D
-5.9%
1Y
36.7%
Haleon
Market Cap: UK£31.9b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.62
7D
-4.9%
1Y
3.6%
Hikma Pharmaceuticals
Market Cap: UK£3.3b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£15.73
7D
-2.5%
1Y
-17.9%